Novum Pharmaceutical Research Services, a subsidiary of Lambda Therapeutic Research, is a CRO with over 50 years of experience in the industry. Lambda & Novum deliver comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide.
With a focus on secure IT infrastructure and automation, we ensure timely project delivery and strict adherence to global regulatory standards. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
Meet us at AAD Annual Meeting 2026
Novum Pharmaceutical Research Services and Lambda Therapeutic Research are excited to announce their participation in AAD Annual Meeting 2026, at Denver, Colorado, which will take place from 27 to 31 March 2026.
With experience in over 105 dermatology studies across diverse indications, enrolling 42,000+ patients across 1,400+ sites, our teams bring experience in complex study designs, diverse patient populations, and global site management strategies.
We welcome the opportunity to discuss your upcoming dermatology programs and explore how our capabilities can support your development objectives. To schedule a meeting, please fill out this form or email us at .